Fayngersh, Miron
Fayngersh, Miron was paid $110K by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 74% of everything it billed.
33Billing provider infoFAYNGERSH, MIRON
BROOKLYN, NY 11230
BROOKLYN, NY 11230
33aNPI1902918279assigned 08/31/2006
33bProvider typeSpecialist
28Total paid$110K
24GClaims22,869
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#462 of 1,221
Median peer was paid$45K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,274 | $11K | |
| 2019 | 3,337 | $9K | |
| 2020 | 2,702 | $10K | |
| 2021 | 3,655 | $15K | |
| 2022 | 2,242 | $17K | |
| 2023 | 2,583 | $18K | |
| 2024incomplete | 4,076 | $30K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 74% | 10,319 | 6,598 | $82K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6.5% | 1,785 | 876 | $7K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.0% | 312 | 300 | $7K |
| 95886 | 2.4% | 184 | 179 | $3K | |
| J3415 | Injection, pyridoxine hcl, 100 mg | 2.4% | 1,085 | 520 | $3K |
| 64483 | 2.0% | 132 | 123 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1.9% | 1,292 | 1,131 | $2K |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 1,083 | 520 | $665.29 |
| 27093 | <1% | 40 | 40 | $492.44 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 474 | 265 | $412.11 |
| 10007 | <1% | 29 | 26 | $411.85 | |
| 20610 | <1% | 113 | 87 | $391.95 |
22 more codes
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,442 | $364.87 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 54 | $289.67 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 40 | $259.23 |
| 73525 | <1% | 40 | $256.88 | |
| 64445 | <1% | 85 | $190.44 | |
| 27369 | <1% | 12 | $160.91 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,776 | $158.26 |
| 77002 | <1% | 58 | $144.15 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 139 | $128.08 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 210 | $122.74 |
| 73580 | <1% | 12 | $116.35 | |
| 64484 | <1% | 27 | $89.21 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 342 | $82.72 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 315 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 314 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 42 | $0.00 |
| 97035 | 0% | 317 | $0.00 | |
| 97124 | 0% | 313 | $0.00 | |
| 95911 | 0% | 12 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 148 | $0.00 |
| 97032 | 0% | 311 | $0.00 | |
| 95910 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.